| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Orexigen Therapeutics, Inc. | 1,229,287 | 6,085,000 | 40.17% | ||
| 2 | ACCELERON PHARMA | 162,070 | 5,128,000 | 33.85% | ||
| 3 | BioDelivery Sciences International Inc | 494,468 | 3,936,000 | 25.98% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-049190, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
